Becker's Healthcare December 30, 2024
What remains after the passing of former President Jimmy Carter encompasses more than politics and humanitarianism, it also includes cancer care, according to a Dec. 29 NBC News report.
Diagnosed with metastatic melanoma in 2015 at the age of 90, Mr. Carter was one of the first public figures to speak openly about immunotherapy. He was treated with the drug pembrolizumab, relatively new at the time and sold as Keytruda, the report said.
Mr. Carter’s willingness to talk about immunotherapy increased attention and interest in the growing field, Amod Sarnaik, MD, professor of cutaneous oncology and immunology at Tampa, Fla.-based Moffitt Cancer Center, told NBC News.
Suresh Ramalingam, MD, executive director of Atlanta-based Emory University’s Winship Cancer...
Today's Sponsors
Today's Sponsor